M MARAVAI LIFESCIENCES HLDGS I
| Market Cap | $1.08B |
| P/E Ratio | — |
| Forward P/E | -19.99 |
| Dividend Yield | — |
| Beta | 0.43 |
| 52W Range | $1.72 - $4.02 |
| # Hedge Funds | 2 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 2 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Steven Romick First Pacific Advisors | 0.04% | $2.88M | 884,883 | — |
| First Eagle Investment Management First Eagle Investment Management | 0.01% | $5.85M | 1,799,336 | Add 299.03% |
Insider Trading
| Insider Name of the company insider who made the trade 5 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| LUCIER GREGORY T | Buy | 48,528 | $3.67 | $178.10K | 08 Dec 2025 | 09 Dec 2025 |
| LUCIER GREGORY T | Buy | 51,472 | $3.70 | $190.45K | 05 Dec 2025 | 09 Dec 2025 |
| Brust BerndChief Executive Officer | Buy | 216,212 | $3.25 | $702.69K | 13 Nov 2025 | 17 Nov 2025 |
| Brust BerndChief Executive Officer | Buy | 93,358 | $3.21 | $299.68K | 12 Nov 2025 | 13 Nov 2025 |
| Brust BerndChief Executive Officer | Buy | 157,201 | $3.24 | $509.33K | 11 Nov 2025 | 13 Nov 2025 |
Frequently Asked Questions
What is MRVI stock price today?
MARAVAI LIFESCIENCES HLDGS I (MRVI) is currently trading at $2.95. The stock has a 52-week range of $1.72 to $4.02 and a market capitalization of $1.08B.
Is MRVI a good stock to buy in 2026?
MARAVAI LIFESCIENCES HLDGS I has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +40.5%. 2 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling MRVI stock?
There have been 5 insider transactions for MRVI in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has MRVI stock performed over the past year?
MARAVAI LIFESCIENCES HLDGS I (MRVI) has returned +40.5% over the past 12 months. The stock traded between $1.72 and $4.02 during this period, and is currently at $2.95.
Which hedge funds own MRVI (MARAVAI LIFESCIENCES HLDGS I)?
2 tracked hedge funds currently hold MRVI in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is MRVI's market cap and valuation?
MARAVAI LIFESCIENCES HLDGS I (MRVI) has a market capitalization of $1.08B. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is MRVI's revenue and profitability?
MARAVAI LIFESCIENCES HLDGS I reported revenue of $185.74M with net income of N/A and a profit margin of N/A. The stock has a beta of 0.43.
What sector is MRVI in and who are its biggest institutional holders?
MARAVAI LIFESCIENCES HLDGS I (MRVI) operates in the Healthcare sector. It is held by 2 tracked hedge funds. See the ownership table above for the complete list.